Pharmacy Residency Program Health System Pharmacy Administration and Leadership with Masters Residency Program

PGY1/PGY2/MS Health System Pharmacy Administration Residency

The Pharmacy Residency Program is a 24-month program, resulting in an MS degree in Pharmacy Leadership & Administration from the University of Houston, as well as a Post-Graduate Year 1 (PGY1) and Post-Graduate Year 2 (PGY2) certificate, upon successful completion.

A PGY2 health-system pharmacy administration and leadership residency builds upon PGY1 residency graduates’ competence in the delivery of patient-centered care and in pharmacy operational services to prepare residents who can assume high level managerial, supervisory, and leadership responsibilities. Areas of competence emphasized during the program include safe and effective medication-use systems, quality assurance and improvement, the management of human resources, the management of financial resources, use of technology, and advanced leadership. The residency lays the foundation for continued growth in management and leadership skills.

The Harris Health System's Department of Pharmacy will train pharmacists to be adept and skilled in multiple areas of direct patient care, to exercise leadership in improving medication safety, and to use administrative skills for health system improvement. Residents will strengthen their commitment to the profession of pharmacy and in turn, train the next generation of healthcare leaders.

Meet Our Residents ›

Requirements

Presentations

Each resident is expected to present a formal case, a journal review, and/or administrative topic review to pharmacy staff as required for rotation.

Service Component

Each Pharmacy Administration resident is expected to staff every third weekend and every third Friday evening on a rotational basis (year 1 and year 2).

Projects

Each resident is expected to plan, design, and complete at least one major project with the guidance of a project mentor per year. As well as two minor project, such as a medication use evaluation (MUE) per year.

Core Rotations

  • Administration
  • Automation/IT
  • Clinical Services
  • Financial Management
  • Human Resources
  • Internal Medicine
  • Operations
  • P&T Formulary Management
  • Primary Care
  • Quality and Regulatory

Elective Rotations

Residents may repeat any core rotation in which they have a particular interest. Elective rotations may be selected from, but are not limited to:

  • Anticoagulation
  • Contract Management
  • Critical Care
  • Emergency Medicine
  • Endocrinology
  • HIV/AIDS
  • Infectious Diseases
  • Inventory Management
  • Investigational Drugs
  • Medication Safety
  • Oncology
  • Pediatrics

Practice Management

Each resident shall be expected to:

  • Provide coverage as Operations-On-Call manager and other consult services.
  • Attend and participate in Pharmacy and Therapeutics Committee, Medication Use Safety Committee, and subcommittee meetings.
  • Develop or revise Policy and Procedures.

Frequently Asked Questions

What are the program's admission requirements?

Individuals wishing to apply to the Harris Health Residency Program must:

  • Be a graduate of an ACPE­-accredited College of Pharmacy
  • Have a current valid pharmacy license in the state of Texas, or be eligible for licensure
  • Have a 3.0 cumulative grade point average for pharmacy school curriculum (on a 4.0 scale)
  • Enroll in the Residency Matching Program
  • Submit application materials through the Pharmacy Online Residency Centralized Application Service (PhORCAS) System by December 31, 2019
  • All PGY1/PGY2/MS candidates must also complete the application process for the University of Houston (UH) Master's Program by January 3, 2020

What are the licensing requirements?

Applicants to the Harris Health System Pharmacy Residency Programs shall have either obtained a license to practice pharmacy in Texas, have reciprocated their license to practice pharmacy in Texas, or be in the process of obtaining their license to practice pharmacy in Texas as soon as possible.

Resident interns and resident pharmacists shall submit documentation of active licensure in the state of Texas [North American Pharmacist Licensure Examination (NAPLEX) and Multistate Pharmacy Jurisprudence Examination (MPJE)] to the Residency Program Director as soon as it is available and no later than July 31, 2020.

Per ASHP requirements, a minimum of 2/3 of the residency must be completed as a licensed pharmacist, therefore resident interns/pharmacists who have failed to meet the licensure deadline (July 31st) due to failure of either the NAPLEX or Texas MPJE exam shall be dismissed from the residency program.

Can Harris Health sponsor applicants with visas?

Harris Health cannot sponsor student work visas.

Are applicants graduating in August considered?

Applicants must graduate by May from an ACPE­-accredited College of Pharmacy.

What documents are required for program application?

Applications shall be deemed complete upon receipt of the following:

  • Curriculum Vitae
  • Letter of Interest
    • Describe your reasons for pursuing a PGY1/PGY2/MS Pharmacy Administration Residency. The letter should include details about your professional interests, achievements, and your five-year goals as a pharmacist
  • Official Transcripts
    • Official transcripts related to pharmacy education are required
    • All other official transcripts from undergraduate education are required
  • Three (3) Letters of Recommendation
    • Reference writers must complete the standardized reference form in the PhORCAS system.
  • Completed application to the University of Houston College of Pharmacy MS Program

What is the official start date of the program?

The official start date of the program is July 1, 2020.

Can the program extend beyond the Residency Class?

Residents will not be allowed to extend the program with or without pay beyond the allotted 24 months of Resident year.

When is the application deadline?

All PHORCAS application documents must be received by December 31, 2019. All University of Houston application documents must be received by January 3, 2020. Early application to the program is highly recommended.

For additional information, please contact:

Goldina Erowele, PharmD, MBA
Residency Program Director
Administrative Director, Clinical Pharmacy Services
Goldina.Erowele@harrishealth.org
Abel Davila, RPH, Ed.D
Residency Program Coordinator
Pharmacy Practice Advancement Manager
Abel.Davila@harrishealth.org
Oge Amaka, Pharm.D.
PGY2 Health-System Pharmacy Administration Resident
Chief Pharmacy Resident
ogechukwu.amaka@harrishealth.org